Predict your next investment

Venture Capital
digitalisventures.com

See what CB Insights has to offer

Investments

40

Funds

3

About Digitalis Ventures

Digitalis Ventures is a venture capital firm focused on investing in seed- and venture-stage companies building technology-enabled solutions to complex problems particularly in the area of human health. Digitalis Ventures (f/k/a Mars Ventures) spun out of Mars, Inc. in February 2016. Digitalis Ventures maintains a strategic affiliation with Mars allowing portfolio companies exposure to the global food giant.

Digitalis Ventures Headquarter Location

640 Eighth Avenue 15th Floor, Suite A

New York, New York, 10036,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Digitalis Ventures News

Nuvig Therapeutics Closes $47M Series A Financing

May 12, 2022

Nuvig Therapeutics , a Redwood City, CA-based developer of therapies that induce mechanisms of immune homeostasis and treat autoimmune diseases without compromising normal immune function, raised $47M in Series A funding. The round was led by Novo Holdings A/S and Platanus, with participation from Bristol Myers Squibb, Digitalis Ventures, and Mission BioCapital. The company intends to use the funds to expand its development efforts. Led by Pamela Conley, Ph.D., Chief Executive Officer, Nuvig Therapeutics offers protein therapies that are designed to induce natural mechanisms to restore immune homeostasis, rebalance immune function following inflammation, and improve the treatment options for patients. Nuvig is building a pipeline of immune therapeutics for chronic inflammatory and autoimmune diseases. FinSMEs

Digitalis Ventures Investments

40 Investments

Digitalis Ventures has made 40 investments. Their latest investment was in Nuvig Therapeutics as part of their Series A on May 5, 2022.

CBI Logo

Digitalis Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/11/2022

Series A

Nuvig Therapeutics

$47M

Yes

3

2/15/2022

Series A

Terray Therapeutics

$60M

No

8

1/31/2022

Seed VC

Ness

$15.5M

Yes

2

1/18/2022

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

12/22/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/11/2022

2/15/2022

1/31/2022

1/18/2022

12/22/2021

Round

Series A

Series A

Seed VC

Seed VC

Series B

Company

Nuvig Therapeutics

Terray Therapeutics

Ness

Subscribe to see more

Subscribe to see more

Amount

$47M

$60M

$15.5M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

8

2

10

10

Digitalis Ventures Fund History

3 Fund Histories

Digitalis Ventures has 3 funds, including Companion Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

3/9/2018

Companion Fund

Multi-Stage Venture Capital

Closed

$100M

1

1/4/2017

Digitalis Ventures Fund I

Subscribe to see more

Subscribe to see more

$99M

10

Digitalis Seed Fund

10

Closing Date

3/9/2018

1/4/2017

Fund

Companion Fund

Digitalis Ventures Fund I

Digitalis Seed Fund

Fund Type

Multi-Stage Venture Capital

Subscribe to see more

Status

Closed

Subscribe to see more

Amount

$100M

$99M

Sources

1

10

10

Digitalis Ventures Team

1 Team Member

Digitalis Ventures has 1 team member, including current Managing Partner, Geoffrey W. Smith.

Name

Work History

Title

Status

Geoffrey W. Smith

Managing Partner

Current

Name

Geoffrey W. Smith

Work History

Title

Managing Partner

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.